Cannabis Countdown: Top 10 Marijuana And Psychedelic Stock News Stories Of The Week

Welcome to the Cannabis Countdown. In This Week’s Edition, We Recap and Countdown the Top 10 Marijuana and Psychedelic Stock News Stories for the Week of October 19th – 25th, 2020.

Without further ado, let’s get started.

* Yahoo Finance readers, please click here to view the full article.

10. Dan Bilzerian to Purchase $20 Million in Ignite International Outstanding Debt

It Seems That Recent Twitter Comments From the Pot Stocks Community Might Be Getting to Dan Bilzerian, if Only Slightly

Ignite International Brands BILZF issued a news release headlined as “Chairman of the Board Intends To Acquire $25 Million of IGNITE Shares.” While it might sound exciting at first, essentially Dan Bilzerian will be purchasing certain outstanding debt and settling it with equity, while also subscribing to a $5.0 million private placement.

READ FULL IGNITE ARTICLE

9. Psychedelics Company Delic Corp. to Go Public on the CSE

The Closing of the RTO Will Take Place By November 30, With More Details to Be Released Soon

E-commerce and events company Delic Corp., which is focused on the Psychedelics industry, recently announced it would be going public on the ‎Canadian Securities Exchange (CSE) via a reverse takeover (RTO) of Molystar Resources Inc.

READ FULL DELIC IPO ARTICLE

8. When Will U.S. Marijuana Stocks Be Profitable?

Recurring Profitability is Expected Next Year for This Group of Pot Stocks

For the lion’s share of U.S. Multi-State Operators (MSOs), recurring profitability is expected in 2021. According to Wall Street‘s consensus estimates, the following five U.S. Marijuana Stocks are forecast to deliver a full-year 2021 profit:

READ FULL U.S. POT STOCKS ARTICLE

7. Numinus Becomes First Canadian Public Company to Complete Legal Harvest of Psilocybe Mushrooms

Numinus Bioscience’s Developments Include Harvesting its First Flush of Psilocybe Mushrooms at its Health Canada Licensed Facility

Numinus Wellness LKYSD, a company creating an ecosystem of health solutions centered on developing and supporting the safe, evidence-based, accessible use of Psychedelic-assisted psychotherapies, has harvested the first legal flush of Psilocybe mushrooms in Canada by a public company under its Health Canada-issued Controlled Drugs and Substances Dealer’s Licence.

READ FULL NUMINUS ARTICLE

6. Stifel: “We View Green Thumb As The Best In Class Operator in U.S. Cannabis”

Stifel GMP Released Their Top Picks for the Fourth Quarter of 2020, Headlining the Note With “Finding Opportunity for Fundamental Investors”

Analyst Andrew Partheniou reiterated his buy rating and C$42.50 price target for Green Thumb Industries GTBIF within the note. Partheniou comments on the rating saying, “We view GTII as the best-in-class operator in the US cannabis industry.”

READ FULL GTII ARTICLE

5. Revive Therapeutics Signs Supply Agreement With Havn Life Sciences for Psychedelic Compounds

Expanding Research and Development of Naturally-Derived Psilocybin for Future FDA IND-Enabling and Clinical Studies

Revive Therapeutics RVVTF announced it has signed a supply agreement with Havn Life Sciences HAVN to source naturally-derived Psychedelic compounds, such as Psilocybin, for use in future investigational new drug (IND) enabling studies and clinical trials under the FDA guidelines.

READ FULL REVIVE ARTICLE

4. 3 Pot Stocks That Should Crush Wall Street’s EPS Expectations

These Cannabis Companies Are Beginning to Separate Themselves From the Pack

As we barrel headlong into Earnings season, investors should keep their eyes on the following trio of Marijuana Stocks, as they look to have the best chance of absolutely crushing Wall Street‘s earnings per share (EPS) expectations for the recently completed quarter.

READ FULL WALL STREET EPS ARTICLE

3. Field Trip Health Continues Expansion With Psychedelic-Enhanced Therapy Center in Chicago

The Chicago Location is the Third Field Trip Center to Open in the U.S. This Year, Providing an Opportunity to Continue Normalizing the Use of Psychedelics in Healing Across the Country

Field Trip Health FTRPF, the global leader in the development and delivery of technology-enabled Psychedelic therapies, announced today the opening of their Chicago center. Located at 325 West Huron Street, Suite 603, the Chicago location is the fourth Field Trip Health center to open this year, following Toronto, New York and Los Angeles.

READ FULL FIELD TRIP ARTICLE

2. Why Canadian Cannabis Operators Benefit From U.S. Election Enthusiasm

While the Market for Cannabis Stocks Has Become More Rational Over the Years, it is Far From Efficient

While American Multi-State Operators (MSOs) are clearly more leveraged to the 2020 Election, we aren’t surprised that there has been a spillover into the Canadian Licensed Producers (LPs). One reason is truly comical…

READ FULL CANNABIS STOCKS ELECTION ARTICLE

1. The Potential $100 Billion Psychedelics Boom Investors Should Watch

Much Like Cannabis, Psychedelics Are Quickly Going Mainstream – and Fast, Most Notably Psilocybin

As the story continues to explode, some of the top Psychedelic Stocks to watch include Revive Therapeutics RVVTF, MindMed MMEDF, Compass Pathways CMPS, Numinus Wellness LKYSD, and Johnson & Johnson JNJ.